|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.37 USD | +3.06% |
|
-2.12% | -15.89% |
| Jun. 05 | Transcript : AIM ImmunoTech Inc. - Special Call | |
| May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 |
Hemispherx Biopharma, Inc. appointed Thomas Equels as President. Equels has served as Executive Vice Chairman, Chief Financial Officer, Secretary and General Counsel of Hemispherx.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.89% | 21.14M | |
| +20.12% | 126B | |
| +25.25% | 119B | |
| +25.56% | 27.95B | |
| -19.51% | 20.5B | |
| -14.36% | 17.12B | |
| -15.63% | 16.1B | |
| -46.67% | 14.97B | |
| +11.89% | 14.84B | |
| +57.74% | 14.38B |
AIM IMMUNOTECH INC. 
